Keyword: GlaxoSmithKline

Research & development (Image: AstraZeneca)

The top 10 highest paid biopharma R&D executives in 2018

The top research and development executives from across biopharma are certainly not looking down the back of the sofa for change; most are earning around $7 million a year. But then the job is tough, and arguably just as important as the top CEO job, given how much companies rely on the strength of their R&D.

The MELLODDY project

Short for Machine Learning Ledger Orchestration for Drug Discovery, the three-year project from the Innovative Medicines Initiative hopes to build an AI platform capable of ingesting large libraries of proprietary information while protecting its confidentiality.

The ATOM Consortium

The consortium intends to make new tools, models and processes broadly available, with a large focus on solutions geared toward cancer patients.